文献速递医学人工智能与信息学临床试验与 GCP真实世界研究与卫生经济

基于人工智能的预测模型在结直肠癌手术决策支持中的临床实施

Clinical implementation of an AI-based prediction model for decision support for patients undergoing colorectal cancer surgery.
PubMed 文献 · Nat Med · 2025-09-18

研究利用丹麦国家登记系统18403例结直肠癌患者及单中心连续患者数据,开发、验证并临床实施人工智能风险预测模型作为围手术期个体化治疗决策支持工具。模型验证集AUC为0.79;非随机前后队列显示个体化治疗组综合并发症指数>20发生比例为19.1%,标准治疗组为28.0%,校正比值比为0.63(95%CI 0.42-0.92;P=0.02)。

要点

  • 基于登记数据的AI模型预测结直肠癌手术1年死亡风险,验证集AUC为0.79。
  • 个体化治疗组综合并发症指数>20比例为19.1%,标准治疗组为28.0%,校正比值比0.63。
  • 个体化治疗组任何医学并发症发生率为23.7%,标准治疗组为37.3%,比值比0.53。

核心结论

  • 研究展示了一种完全可扩展的、基于登记系统的方法,可在临床实践中将现有数据用于基于人工智能的决策支持流程。
  • 结果表明这一特定方法可能成为改善关键手术临床结局的成本有效策略。

研究设计与样本

  • 使用丹麦国家登记系统18403例结直肠癌患者的真实世界数据及单中心连续患者,开发、验证并在临床实践中实施基于人工智能的风险预测模型,作为个体化围手术期治疗的决策支持工具。
  • 根据预测的1年死亡风险设计个体化治疗路径,干预强度随预测风险增加而增加。
  • 采用非随机前后队列研究评估实施效果。

主要发现

  • 开发模型在验证集的受试者工作特征曲线下面积为0.79。
  • 非随机前后队列研究显示,综合并发症指数>20的发生比例在个体化治疗组为19.1%,标准治疗组为28.0%,校正比值比为0.63(95%CI 0.42-0.92;P=0.02)。
  • 任何医学并发症的发生率在个体化治疗组为23.7%,标准治疗组为37.3%,比值比为0.53(95%CI 0.36-0.76;P<0.001)。
  • 根据短期健康经济学建模,个体化围手术期治疗具有成本有效性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Adverse outcomes after elective cancer surgery are a main contributor to decreased survival, poorer oncological outcomes and increased healthcare costs. Identifying high-risk patients and selecting interventions according to individual risk profiles in the perioperative period in cancer surgery is a challenge. Using real-world data on 18,403 patients with colorectal cancer from Danish national registries and consecutive patients from a single center, we developed, validated and implemented an artificial-intelligence-based risk prediction model in clinical practice as a decision support tool for personalized perioperative treatment. Personalized treatment pathways were designed according to the predicted risk of 1-year mortality with the intensity of interventions increasing with the predicted risk. The developed model had an area under the receiver operating characteristic curve of 0.79 in the validation set. Results from the nonrandomized before/after cohort study showed an incidence proportion of the comprehensive complication index >20 of 19.1% in the personalized treatment group versus 28.0% in the standard-of-care group, adjusted odds ratio of 0.63 (95% confidence interval, 0.42-0.92; P = 0.02). The incidence of any medical complication was 23.7% in the personalized treatment group and 37.3% in the standard-of-care group; odds ratio of 0.53 (95% confidence interval, 0.36-0.76; P < 0.001). According to the short-term health economic modeling, personalized perioperative treatment was cost effective. The study demonstrates a fully scalable registry-based approach for using readily available data in an artificial-intelligence-based decision support pipeline in clinical practice. Our results indicate that this specific approach can be a cost-effective strategy to improve key surgical clinical outcomes.

来源:Nat Med,查看原文。版权归原作者所有。

引用

  1. Rosen AW, Ose I, Gögenur M, et al. Clinical implementation of an AI-based prediction model for decision support for patients undergoing colorectal cancer surgery. Nat Med. 2025. PMID: 40968272. doi:10.1038/s41591-025-03942-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。